Predictive Utility of Patient Reported Outcomes for Survival in 1st-Line Treated Patients with a NSCLC in EMPOWER-Lung 1 and 3

Abstract

Description

Keywords

Cemiplimab, Advanced non-small cell lung cancer, Patientreported outcomes

Citation

Endorsement

Review

Supplemented By

Referenced By